CLNN
Clene Inc.
Key Financials
Revenue
$200000
↓ 41.5%
Operating Income
$-23083000
↑ 30.2%
Net Income
$-26173000
↑ 33.6%
Total Liabilities
$35.7M
↓ 1.3%
EPS (Diluted)
$-0.46
N/A
Shareholders' Equity
$-17592000.00
↓ 98.6%
Total Assets
$18.1M
↓ 33.7%
Long-term Debt
$17.8M
N/A
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 10/13/2026 | View on SEC |
| 4 | 9/18/2026 | View on SEC |
| 4 | 9/18/2026 | View on SEC |
| 4 | 9/18/2026 | View on SEC |
| 8-K | 9/16/2026 | View on SEC |
| 424B5 | 9/16/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| 4 | 8/14/2026 | View on SEC |
| 4 | 8/14/2026 | View on SEC |
| 4 | 8/14/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CLNN |
| Company Name | Clene Inc. |
| CIK | 1822791 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 801-676-9695 |